Silver alloy coated catheters reduce catheter-associated bacteriuria

Area of Science:

• Urology
• Infectious Diseases
• Biomaterials Science

Background:

• Urinary tract infections (UTIs) are a common complication associated with indwelling urinary catheters.
• Catheter-associated bacteriuria (CAB) significantly increases morbidity and healthcare costs.
• Novel catheter materials are needed to mitigate infection risk.

Purpose of the Study:

• To evaluate the efficacy of a novel silver alloy-coated Foley catheter in preventing catheter-associated bacteriuria (CAB).
• To compare the incidence of CAB between silver alloy-coated catheters and standard Teflonised latex catheters.

Main Methods:

• A randomized clinical trial involving 223 patients requiring indwelling urinary catheters.
• Patients were allocated to receive either a silver alloy-coated Foley catheter (n=60) or a standard Teflonised latex Foley catheter (n=60).
• Exclusion criteria included antibiotic treatment and diabetes; 103 patients were excluded.

Main Results:

• A statistically significant reduction in CAB (defined as >10(5) organisms/ml) was observed in the silver alloy catheter group after 6 days of catheterization.
• Only 6 patients with silver alloy catheters developed bacteriuria compared to 22 patients with Teflonised latex catheters.
• This represents a substantial decrease in the incidence of catheter-associated urinary tract infections.

Conclusions:

• Silver impregnated urethral catheters demonstrate a significant potential to reduce the incidence of catheter-associated urinary tract infections.
• The use of silver alloy coatings on Foley catheters is a promising strategy for infection prevention in catheterized patients.
• Further research should explore long-term efficacy and broader clinical applications.